Compare APPN & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APPN | PAHC |
|---|---|---|
| Founded | 1999 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2017 | 2014 |
| Metric | APPN | PAHC |
|---|---|---|
| Price | $23.19 | $53.95 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $33.83 | ★ $34.33 |
| AVG Volume (30 Days) | ★ 633.3K | 258.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | 101.59 | ★ 1883.33 |
| EPS | 0.02 | ★ 1.32 |
| Revenue | $226,743,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $13.79 | $17.03 |
| Revenue Next Year | $10.56 | $3.82 |
| P/E Ratio | $1,199.50 | ★ $42.28 |
| Revenue Growth | ★ 28.29 | 4.12 |
| 52 Week Low | $21.77 | $16.16 |
| 52 Week High | $46.06 | $57.62 |
| Indicator | APPN | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 55.44 |
| Support Level | $21.77 | $37.09 |
| Resistance Level | $31.10 | $56.14 |
| Average True Range (ATR) | 0.95 | 2.43 |
| MACD | -0.16 | 0.22 |
| Stochastic Oscillator | 4.89 | 57.90 |
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.